医薬品トレーサビリティ市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

医薬品トレーサビリティ市場の2023年の市場規模は150億1,000万米ドルで、2024年には184億8,000万米ドルに達すると予測され、CAGR 23.54％で成長し、2030年には659億9,000万米ドルに達すると予測されています。

医薬品トレーサビリティは、医薬品の製造、流通、調剤を追跡する機能を指します。その範囲には、偽造医薬品に対抗し、患者の安全性と規制遵守を確保するために設計された、シリアル化、追跡、検証システムが含まれます。医薬品トレーサビリティの必要性は、米国医薬品サプライチェーンセキュリティ法（DSCSA）やEUの偽造医薬品指令（FMD）のような、医薬品の製造から販売までの完全なトレーサビリティを要求する厳しい世界の規制義務に後押しされています。アプリケーションは、製造業者から卸売業者、薬局、ヘルスケアプロバイダーまで、サプライチェーン全体に及び、透明性と安全性を高めます。エンドユースの範囲には、主に医薬品メーカー、ヘルスケア・ディストリビューター、薬局、ヘルスケアの提供と安全に重点を置く政府機関などが含まれます。この市場に影響を与える主な成長要因には、偽造医薬品の増加、透明性の高い監視が必要な複雑なサプライチェーン業務、追跡とデータ整合性を改善するためのブロックチェーンとIoTの技術進歩などがあります。予測的洞察、リアルタイムの意思決定の改善、ロジスティクスの最適化のための高度な分析とAIの統合には機会が存在します。しかし、高額な導入コスト、データプライバシーに関する懸念、新システムの採用に対する抵抗感などの課題が、成長の妨げになる可能性があります。さらに、世界の規制状況の断片化により、一貫したコンプライアンス戦略が必要となっています。イノベーションは、普遍的なトレーサビリティ標準の開発、国境を越えた相互運用性の強化、不変の記録のためのブロックチェーン技術の活用にあります。安全でありながら費用対効果の高いトレーサビリティ・ソリューションのさらなる調査も、地域によって異なる規制の要求に適合させることで、成長を刺激すると思われます。市場のダイナミックな性質は、持続可能性とコスト効率に焦点を当てた技術的ソリューションの絶え間ない進化を示唆しており、厳しい規制の枠組みの中で革新を求める企業に広くアピールしています。

市場力学：急速に進化する医薬品トレーサビリティ市場の主要市場インサイトを公開

医薬品トレーサビリティ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 偽造医薬品の増加
  • 医薬品に関する政府の厳しい規制
  • 医薬品取引の大幅な増加
• 市場抑制要因
  • ソリューションのコスト高
• 市場機会
  • 医薬品トレーサビリティ向けスマートソリューションのイントロダクション
  • 戦略的提携と投資の増加
• 市場の課題
  • 医薬品のシリアル化に関する一般的な規格の未整備

ポーターの5つの力：医薬品トレーサビリティ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品トレーサビリティ市場における外部からの影響の把握

外部マクロ環境要因は、医薬品トレーサビリティ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品トレーサビリティ市場における競合情勢の把握

医薬品トレーサビリティ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品トレーサビリティ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品トレーサビリティ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品トレーサビリティ市場における成功への道筋を描く

医薬品トレーサビリティ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 偽造医薬品の増加
    • 医薬品に対する政府の厳しい規制
    • 医薬品取引の大幅な増加
  • 抑制要因
    • ソリューションの高コスト
  • 機会
    • 医薬品トレーサビリティのスマートソリューションのイントロダクション
    • 戦略的提携と投資の増加
  • 課題
    • 医薬品のシリアル番号付けに関する一般的な基準がない
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品トレーサビリティ市場：タイプ別

• バーコード
• GPS
• RFID

第7章 医薬品トレーサビリティ市場：エンドユーザー別

• 病院
• 薬局

第8章 南北アメリカの医薬品トレーサビリティ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の医薬品トレーサビリティ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの医薬品トレーサビリティ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Alien Technology LLC
• AlpVision SA
• Authentix Inc.
• Avery Dennison Corporation
• Bar Code India Ltd.
• Cognex Corporation
• Datalogic S.p.A.
• Dover Corporation
• Impinj Inc.
• Mettler Toledo International Inc.
• Movilitas Consulting AG
• Optel Group
• rfxcel Corp.
• SATO Holdings Corp.
• TraceLink Inc.
• Zebra Technologies Corp.

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL TRACEABILITY MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL TRACEABILITY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL TRACEABILITY MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY BARCODE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY GPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY RFID, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM PHARMACEUTICAL TRACEABILITY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. PHARMACEUTICAL TRACEABILITY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. PHARMACEUTICAL TRACEABILITY MARKET, FPNV POSITIONING MATRIX, 2023

The Pharmaceutical Traceability Market was valued at USD 15.01 billion in 2023, expected to reach USD 18.48 billion in 2024, and is projected to grow at a CAGR of 23.54%, to USD 65.99 billion by 2030.

Pharmaceutical traceability refers to the ability to track the production, distribution, and dispensing of pharmaceutical products. Its scope encompasses serialization, tracking, and verification systems designed to combat counterfeit drugs, ensuring patient safety and regulatory compliance. The necessity for pharmaceutical traceability is driven by stringent global regulatory mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD), which require full traceability of pharmaceuticals from manufacturing to the point of sale. Applications span across the entire supply chain, from manufacturers to wholesalers, pharmacies, and healthcare providers, enhancing transparency and safety. The end-use scope primarily includes drug manufacturers, healthcare distributors, pharmacies, and governmental agencies focused on healthcare delivery and safety. Key growth factors influencing this market include increasing incidents of counterfeit drugs, complex supply chain operations necessitating transparent oversight, and technological advancements in blockchain and IoT for improved tracking and data integrity. Opportunities exist in the integration of advanced analytics and AI for predictive insights, improving real-time decision-making and optimizing logistics. However, challenges such as high implementation costs, data privacy concerns, and the resistance to adopting new systems may hinder growth. Moreover, the fragmentation of the global regulatory landscape necessitates consistent compliance strategies. Innovation lies in the development of universal traceability standards, enhancing interoperability across borders, and leveraging blockchain technology for immutable records. Additional research into secure yet cost-effective traceability solutions, adapted to varying regional regulatory demands, will also stimulate growth. The market's dynamic nature suggests a constant evolution of technological solutions, with a keen focus on sustainability and cost efficiency, appealing widely to firms seeking to innovate within stringent regulatory frameworks.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Traceability Market

The Pharmaceutical Traceability Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing presence of counterfeit drugs
  • Strict governmental regulations for pharmaceutical drugs
  • Significant growth in trades of pharmaceutical products
• Market Restraints
  • High costs of solutions
• Market Opportunities
  • Introduction of smart solutions for pharmaceutical traceability
  • Increasing strategic alliances and investments
• Market Challenges
  • Unavailability of general standards for drug serialization

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Traceability Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Traceability Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Traceability Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Traceability Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Traceability Market

A detailed market share analysis in the Pharmaceutical Traceability Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Traceability Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Traceability Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Traceability Market

A strategic analysis of the Pharmaceutical Traceability Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Traceability Market, highlighting leading vendors and their innovative profiles. These include Alien Technology LLC, AlpVision SA, Authentix Inc., Avery Dennison Corporation, Bar Code India Ltd., Cognex Corporation, Datalogic S.p.A., Dover Corporation, Impinj Inc., Mettler Toledo International Inc., Movilitas Consulting AG, Optel Group, rfxcel Corp., SATO Holdings Corp., TraceLink Inc., and Zebra Technologies Corp..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Traceability Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Barcode, GPS, and RFID.
• Based on End User, market is studied across Hospitals and Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing presence of counterfeit drugs
    • 5.1.1.2. Strict governmental regulations for pharmaceutical drugs
    • 5.1.1.3. Significant growth in trades of pharmaceutical products
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of solutions
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of smart solutions for pharmaceutical traceability
    • 5.1.3.2. Increasing strategic alliances and investments
  • 5.1.4. Challenges
    • 5.1.4.1. Unavailability of general standards for drug serialization
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Traceability Market, by Type

• 6.1. Introduction
• 6.2. Barcode
• 6.3. GPS
• 6.4. RFID

7. Pharmaceutical Traceability Market, by End User

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Pharmacies

8. Americas Pharmaceutical Traceability Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Pharmaceutical Traceability Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Traceability Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Alien Technology LLC
• 2. AlpVision SA
• 3. Authentix Inc.
• 4. Avery Dennison Corporation
• 5. Bar Code India Ltd.
• 6. Cognex Corporation
• 7. Datalogic S.p.A.
• 8. Dover Corporation
• 9. Impinj Inc.
• 10. Mettler Toledo International Inc.
• 11. Movilitas Consulting AG
• 12. Optel Group
• 13. rfxcel Corp.
• 14. SATO Holdings Corp.
• 15. TraceLink Inc.
• 16. Zebra Technologies Corp.